Atlas Trials

An Observational Study of Peginterferon Alfa-2a (PEGASYS®) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

Clinical trial NCT01667432 · COMPLETED

Trial details

NCT number
NCT01667432
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Study type
OBSERVATIONAL
Hepatitis B, Chronic
Start date
2011-07-08
Primary completion
2014-08-12
Enrollment
141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.